The FDA Pharmacy Compounding Advisory Committee meeting in July 2026 will not directly address tirzepatide (it is already approved as a brand drug), but the broader regulatory direction will shape the compounded peptide market for years to come
The questions asked during screening are designed to identify any factors that could potentially harm the donor or compromise the safety and effectiveness of the donated plasma
Extraordinary Potency: Published research describes Dihexa as active at picomolar concentrations-roughly seven orders of magnitude more potent than BDNF in driving new synapse formation in specific assay conditions
This is the best way to prevent a criminal from opening an unauthorized account in your name. According to Rossman, only about 1 in 4 adults in the U.S
I want everyone to know that there is light at the end of the tunnel and Dr
In the above research, imaging studies have been particularly valuable for understanding neural substrates of NPS, revealing a wide range of candidate brain structures with pathological changes associated with each symptom